+ Watch NBS
on My Watchlist
Neostem is making serious medical progress in an area that is right now cutting-edge and will later be commonplace, fitting my investment philosophy completely, It uses adult stem cells, which is encouraged by Catholic social teaching (the Vatican has a $1 million stake in the company).Also, it has Chinese exposure, but it isn't totally dependent on them. It's making good acquisitions and being patient. Profitable within two-three years; stock could rise tenfold.
Watch for a jump near or in November, when a Vatican conference co-sponsored by NBS will take place and raise public awareness of this Micro Cap.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions